Frederic Villard - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Frederic Villard

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Medicinal Chemistry|August 29, 2020

Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral ExposureJuraj Velcicky, Rainer Wilcken, Simona Cotesta, et al.

ACS Medicinal Chemistry Letters|February 20, 2020

Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin InhibitorsToshio Kawanami, Rajeshri G Karki, Emma Cody, et al.

Blood|January 30, 2019

MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humansAlexander W Koch, Nikolaus Schiering, Samu Melkko, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Medicinal Chemistry|August 29, 2020

Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral ExposureJuraj Velcicky, Rainer Wilcken, Simona Cotesta, et al.

ACS Medicinal Chemistry Letters|February 20, 2020

Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin InhibitorsToshio Kawanami, Rajeshri G Karki, Emma Cody, et al.

Blood|January 30, 2019

MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humansAlexander W Koch, Nikolaus Schiering, Samu Melkko, et al.

Pageof 2